Sign in
LTGO Stock Price, Chart, Stats & News
Latigo Biotherapeutics Inc.
Save
Latigo Biotherapeutics Inc. (LTGO) does not currently pay a dividend.
1.35B
Market cap
–
Current P/E
–
Forward P/E
LTGO chart
1M
3M
1Y
5Y
Loading chart...
About
Latigo Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company committed to developing innovative non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its products include Molecule: LTG-001, Molecule: LTG-32, Molecule: LTG-001 IV and Molecule: LTG-418. The company was founded on November 20, 2018 and is headquartered in Thousand Oak, CA.
Similar securities
Based on sector and market capitalization
Report issue